Not applicableStudy completedNCT04757935What this trial is testingYoga for Youth With IBD: a Pilot Feasibility StudyWho this might be right forInflammatory Bowel DiseasesYogaAdolescents+2 more Stanford University 9
Testing effectiveness (Phase 2)Study completedNCT01345318What this trial is testingB0151005 Open-Label Extension StudyWho this might be right forCrohn's Disease Pfizer 191
Not applicableLooking for participantsNCT07305454What this trial is testingImpact of a Structured Therapeutic Education Session on the Practice of Adapted Physical Activity in Chronic Inflammatory Bowel DiseasesWho this might be right forChronic Inflammatory Bowel Disease University Hospital, Toulouse 71
Testing effectiveness (Phase 2)Study completedNCT00291668What this trial is testingClinical Study of CDP870/Certolizumab Pegol in Patients With Active Crohn's DiseaseWho this might be right forCrohn's Disease UCB Pharma 94
Large-scale testing (Phase 3)Ended earlyNCT00206713What this trial is testingEfficacy Study of Sargramostim in the Retreatment of Patients Who Have Crohn's Disease Who Have Previously Responded to Treatment With SargramostimWho this might be right forCrohn Disease Genzyme, a Sanofi Company 264
Testing effectiveness (Phase 2)Study completedNCT01576120What this trial is testingEvaluation of a PillCam Colon Bowel Preparation Regimen in Crohn's Disease PatientsWho this might be right forCrohn's Disease Medtronic - MITG 40
Testing effectiveness (Phase 2)Study completedNCT05013905What this trial is testingA Phase 2a Safety and Efficacy Open-Label Study of Tulisokibart (MK-7240/PRA023) in Participants With Moderately to Severely Active Crohn's Disease (MK-7240-006)Who this might be right forCrohn Disease Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 55
Not applicableUnknownNCT03012542What this trial is testingDiet as Essential Therapy (DIET) for Inflammatory Bowel DiseaseWho this might be right forCrohn Disease University of Washington 32
Early research (Phase 1)Study completedNCT00007163What this trial is testingMonoclonal Antibody Treatment of Crohn's DiseaseWho this might be right forCrohn's Disease National Institute of Allergy and Infectious Diseases (NIAID) 40
Post-approval studies (Phase 4)Ended earlyNCT01802593What this trial is testingComparison of 2 Immunomodulator Withdrawal Schemes for Infliximab Monotherapy in Active Pediatric Crohn's Disease After Thiopurine FailureWho this might be right forCrohn's Disease Prof. Arie Levine 20
Testing effectiveness (Phase 2)Study completedNCT02199561What this trial is testingFecal Microbiota Transplantation (FMT) in the Management of Active Crohn's DiseaseWho this might be right forCrohn's Disease University of Alberta 3
Not applicableEnrolling By InvitationNCT07171593What this trial is testingHigh-protein Oral Nutrition With HMB for Active CD Patients With SarcopeniaWho this might be right forHandgrip Strength Sixth Affiliated Hospital, Sun Yat-sen University 44
Not applicableLooking for participantsNCT04859088What this trial is testingBiologics and Partial Enteral Nutrition StudyWho this might be right forCrohn Disease NHS Greater Glasgow and Clyde 80
Early research (Phase 1)Not Yet RecruitingNCT07791888What this trial is testingR-3750 in Patients With Crohn's DiseaseWho this might be right forCrohn Disease (CD) Rise Therapeutics LLC 40
Large-scale testing (Phase 3)Ended earlyNCT00245505What this trial is testingThe Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease"Who this might be right forCrohn's Disease Ferring Pharmaceuticals 3
Not applicableLooking for participantsNCT07245394What this trial is testingSwitching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)Who this might be right forInflammatory Bowel Disease (IBD)Crohn Disease (CD)Ulcerative Colitis (UC)+1 more TIDHI Innovation Inc. 200
Testing effectiveness (Phase 2)Looking for participantsNCT07483099What this trial is testingLY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's DiseaseWho this might be right forCrohn Disease Eli Lilly and Company 60
Not applicableLooking for participantsNCT02421705What this trial is testingVisceral Sensitivity in IBD (Irritable Bowel Disease) and IBS (Irritable Bowel Syndrome)Who this might be right forIBSUlcerative Colitis, ActiveUlcerative Colitis, Remission (3a: With IBS Symptoms, 3b: Without IBS Symptoms)+3 more KU Leuven 99,999,999
Post-approval studies (Phase 4)Looking for participantsNCT06051253What this trial is testingTDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's DiseaseWho this might be right forCrohn DiseaseInfliximabPerianal Fistula Due to Crohn's Disease+2 more Asan Medical Center 86
Not applicableStudy completedNCT01738529What this trial is testingCharacterization of Crohn's Disease at Confocal Laser Endomicroscopy (CLE) and Related to Disease ActivityWho this might be right forCrohn Disease Herlev Hospital 36